Search Results - James J. Ferguson

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Protein Synthesis and Adrenocorticotropin Responsiveness

    Protein Synthesis and Adrenocorticotropin Responsiveness by James J. Ferguson

    Published 1963
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Photoaffinity Labeling with Cyclic Nucleotides

    Photoaffinity Labeling with Cyclic Nucleotides by Ross S. Antonoff, James J. Ferguson

    Published 1974
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty

    Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty by Amilcar Avendan̄o, James J. Ferguson

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The Biosynthesis of β-Hydroxy-β-methylglutaryl Coenzyme A in Yeast

    The Biosynthesis of β-Hydroxy-β-methylglutaryl Coenzyme A in Yeast by Harry Rudney, James J. Ferguson

    Published 1959
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Yeast Malate Dehydrogenase: Enzyme Inactivation in Catabolite Repression

    Yeast Malate Dehydrogenase: Enzyme Inactivation in Catabolite Repression by James J. Ferguson, Matthias Boll, Helmut Holzer

    Published 1967
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    THE BIOSYNTHESIS OF MEVALONIC ACID

    THE BIOSYNTHESIS OF MEVALONIC ACID by James J. Ferguson, I.F. Durr, Harry Rudney

    Published 1959
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    The relationships of high energy phosphates, tissue pH, and regional blood flow to diastolic distensibility in the ischemic dog myocardium.

    The relationships of high energy phosphates, tissue pH, and regional blood flow to diastolic distensibility in the ischemic dog myocardium. by Shin‐ichi Momomura, Joanne S. Ingwall, J. Anthony Parker, Peter Sahagian, James J. Ferguson, William Grossman

    Published 1985
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Bleeding risks of combination vs. single antiplatelet therapy: a meta‐analysis of 18 randomized trials comprising 129 314 patients

    Bleeding risks of combination vs. single antiplatelet therapy: a meta‐analysis of 18 randomized trials comprising 129 314 patients by Victor L. Serebruany, Alex I. Malinin, James J. Ferguson, Javad Vahabi, Dan Atar, Charles H. Hennekens

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.

    Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. by S K Yao, J C Ober, Ashok Krishnaswami, James J. Ferguson, H. Vernon Anderson, Paolo Golino, L. Maximilian Buja, J. T. Willerson

    Published 1992
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery

    Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery by Jan T. Christenson, Marc Cohen, James J. Ferguson, Robert J. Freedman, Michael F. Miller, E. Magnus Ohman, Ramachandra C. Reddy, Gregg W. Stone, Philip Urban

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.

    Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. by Eric J. Topol, R Bonan, D E Jewitt, Ulrich Sigwart, V V Kakkar, Martin T. Rothman, David de Bono, James J. Ferguson, J T Willerson, John Strony

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention

    Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention by Keaven M. Anderson, Robert M. Califf, Gregg W. Stone, Franz-Josef Neumann, Gilles Montalescot, Dave P. Miller, James J. Ferguson, James T. Willerson, Harlan F. Weisman, Eric J. Topol

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Pharmacodynamic Efficacy, Clinical Safety, and Outcomes After Prolonged Platelet Glycoprotein IIb/IIIa Receptor Blockade With Oral Xemilofiban

    Pharmacodynamic Efficacy, Clinical Safety, and Outcomes After Prolonged Platelet Glycoprotein IIb/IIIa Receptor Blockade With Oral Xemilofiban by Dean J. Kereiakes, Neal S. Kleiman, James J. Ferguson, A.R. Zaki Masud, Thomas M. Broderick, Charles W. Abbottsmith, John Paul Runyon, Linda C. Anderson, Robert J. Anders, Roger J. Dreiling, Gary Hantsbarger, Brian Bryzinski, Eric J. Topol

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease

    Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease by Eric J. Topol, Donald Easton, Robert A. Harrington, Pierre Amarenco, Robert M. Califf, Carmen Graffagnino, Stephen M. Davis, H.C. Diener, James J. Ferguson, Desmond J. Fitzgerald, Jeffrey R. Granett, Ashfaq Shuaib, Peter J. Koudstaal, Pierre Théroux, Frans Van de Werf, Kristina N. Sigmon, Karen S. Pieper, Marc Vallée, James T. Willerson

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial

    Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial by David R. Holmes, Michael P. Savage, J M Lablanche, Lars Grip, P. W. Serruys, Peter J. Fitzgerald, David L. Fischman, Sheldon Goldberg, Jeffrey Brinker, Andreas M. Zeiher, Leonard M. Shapiro, James T. Willerson, Barry R. Davis, James J. Ferguson, Jeffrey J. Popma, Spencer B. King, A. Michael Lincoff, James E. Tcheng, Robert Chan, Jeffrey R. Granett, Marcia Poland

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy

    Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy by James J Ferguson, Robert M. Califf, Elliott M. Antman, Marc Cohen, Cindy L. Grines, Shaun Goodman, Dean J. Kereiakes, Anatoly Langer, Kenneth W. Mahaffey, Christopher C. Nessel, Paul W. Armstrong, Álvaro Avezum, Philip E. Aylward, Richard C. Becker, Luigi M. Biasucci, Steven Borzak, Jacques Col, M Frey, E Fry, Dietrich C. Gulba, Sema Güneri, Enrique Gurfinkel, Robert A. Harrington, Judith S. Hochman, Neal S. Kleiman, Martin B. Leon, José Luis López-Sendón, Carl J. Pepine, Witold Rużyłło, Steven R. Steinhubl, Paul S. Teirstein, Luis O. Toro-Figueroa, Harvey D. White

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: